No insider purchase over the last 90 days. The latest was filed 05 Nov 2025.
Every trade that managers of Aker BioMarine ASA disclose to Oslo Børs is tracked on this page. The company sits in the Food & Beverage sector. The last twelve months, up to 18 October 2026, brought 8 filings signed by 7 insiders.
No insider sold shares on the market over the period. Instead, the filings list 2 purchases totalling €51k, made by 2 insiders. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Trond Atle Smedsrud filed the largest purchase, €47k, on 5 November 2025.
The data flag 1 purchase as part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. The last purchase on record was published on 5 November 2025, which is 346 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, MAR article 19 gives managers three business days to notify a trade.
With 8 filings in twelve months, the company is more active than the median of 4 filings across the 257 companies we follow on the same exchange. Since 2021, the database holds 4 purchases and no sales by insiders of the company.
In the same sector, recent insider purchases at Village Farms International, Inc. and Orkla ASA also feature in our signals. Source: insider filings from Oslo Børs. Past trades are no guide to future returns.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Aker BioMarine ASA Hold (neutral), based on 1 analysts. Average price target: NOK 123.23.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 31 declarations
Aker BioMarine ASA is a Norwegian company specializing in the production of sustainable marine products, particularly krill oil. It focuses on research and development to provide innovative nutritional solutions.
Purchases our model currently ranks for the recommendations list.
All recommendations